EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeting CRBN With Thalidomide Suppresses Fibrosis After Glaucoma Drainage Surgery Through NF-κB Pathway Inhibition

Lijun Wang, Hongsong Li, Lei Xiong, Chao Sun, Jianming Wang

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.3.48 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Lijun Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China. Hauptthemen laut MEDLINE: NF-kappa B, Glaucoma, Thalidomide, Glaucoma Drainage Implants. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Fibrosis after glaucoma drainage surgery (GDS) is the main factor behind glaucoma surgery failures. Previous studies showed that cereblon (CRBN) protein is involved in tissue differentiation, although its role in glaucoma remains unknown. Herein we explored the role of CRBN and its ligand thalidomide (THD) in fibrosis after GDS.

Methods

Using a rat GDS model and TGF-β2-induced cell model, we investigated the functions of CRBN and THD. CRBN expression in Tenon capsule tissue was detected using immunofluorescence. Filtering bleb survival was monitored after surgery. Protein levels of α‑smooth muscle actin (SMA), fibronectin (FN), and proliferating cell nuclear antigen (PCNA) were measured by Western blotting and immunohistochemistry. Activation of the nuclear factor (NF)‑κB pathway was evaluated via detecting P65 and p‑P65 levels.

Results

CRBN expression was upregulated in Tenon capsule tissue after GDS. THD treatment significantly attenuated CRBN expression. Moreover, THD dose-dependently inhibited TGF-β2-induced cell proliferation. Western blotting confirmed that THD suppresses TGF-β2-induced transdifferentiation and proliferation of human Tenon fibroblasts. In vivo, topical THD application prolonged filtering bleb survival and restrained α-SMA expression. Mechanistically, THD inhibited P65 phosphorylation, thereby preventing the activation of the NF-κB pathway.

Conclusions

CRBN is a key protein regulating fibrosis following GDS. THD exerts anti-fibrotic effects by targeting CRBN and inhibiting the NF-κB pathway. These findings unveil a novel intervention target, CRBN, for attenuating fibrogenesis after GDS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BGlaucomaThalidomideGlaucoma Drainage ImplantsAnimalsFibrosisRatsUbiquitin-Protein LigasesHumansDisease Models, AnimalCell ProliferationBlotting, WesternSignal TransductionMaleFibroblastsTenon CapsuleRats, Sprague-DawleyAdaptor Proteins, Signal TransducingCells, CulturedActinsImmunohistochemistry

Substanzen

NF-kappa BUbiquitin-Protein LigasesThalidomideAdaptor Proteins, Signal TransducingCRBN protein, humanActins

Autor:innen und Institutionen

  • Department of Ophthalmology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
  • Department of Ophthalmology, Xi'an No. 1 Hospital, First Affiliated Hospital of Northwest University, Xi'an, Shaanxi Province, China.

Zitieren

APA

Wang, L., Li, H., Xiong, L., Sun, C., & Wang, J. (2026). Targeting CRBN With Thalidomide Suppresses Fibrosis After Glaucoma Drainage Surgery Through NF-κB Pathway Inhibition. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.3.48

Vancouver

Wang L, Li H, Xiong L, Sun C, Wang J. Targeting CRBN With Thalidomide Suppresses Fibrosis After Glaucoma Drainage Surgery Through NF-κB Pathway Inhibition. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.3.48

BibTeX
@article{Wang2026,
  author = {Wang, Lijun and Li, Hongsong and Xiong, Lei and Sun, Chao and Wang, Jianming},
  title = {Targeting CRBN With Thalidomide Suppresses Fibrosis After Glaucoma Drainage Surgery Through NF-κB Pathway Inhibition},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.3.48}
}
Kostenlos starten →